John Beighton

Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland.

Part of Teva Pharmaceutical Industries Ltd., Teva UK Ltd. is a pharmaceutical company that provides medicines to improve the health of millions of patients every day. Teva offers generic, biosimilar, and specialty medicines to help patients take control of their health and help the NHS make the most of its limited resources. The private company was founded in 1935 by Nora Sarsby and Margaret Galloway and is based in Castleford, UK. Teva believes in enforcing strong practices and controls to ensure all activities are carried out ethically and transparently. The British company works with governments and customs authorities to control the problems caused by counterfeit medicines.

Mercury Pharma Group Ltd. develops pharmaceutical and consumer health products. It sells niche prescription pharmaceuticals and non-prescription medicines. The company was founded by Shane Gogerly, Kirti V. Patel, and Ajit R. Patel on December 23, 1988 and is headquartered in London, the United Kingdom.

Smithkline Beecham Ltd. manufacture of basic pharmaceutical products. It also provides mineral water, bottled water, and soft drinks. The company was founded on January 24, 1989 and is headquartered in Brentford, the United Kingdom.

Advanz Pharma Services (UK) Ltd. develops pharmaceutical and consumer health products. It is an international specialty pharmaceutical company providing medicines through its four product ranges: Amdipharm, Mercury Pharma, Abcur, and Focus products. The firm owns a broad portfolio of branded and generic pharmaceutical prescription products. The company was founded on February 26, 2003 and is headquartered in London, the United Kingdom.

ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company engages in the provision of branded and unbranded products. The firm specializes in anti-Infectives and endocrinology therapy areas. It operates through the following segments: Advanz Pharma International; Advanz Pharma North America; and Corporate. The Advanz Pharma International segment include portfolio of branded and generic products that are sold to wholesalers, hospitals, and pharmacies. The Advanz Pharma North America segment comprises branded products and authorized generic contracts that focuses primarily on the U.S. pharmaceutical market. The Corporate segment represents the centralized costs. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in St. Helier, the United Kingdom.